Michael K. Gibson, MD, PhD, FACP, is a medical oncologist, Medical Director of the Head and Neck Team of University Hospitals Seidman Cancer Center and Medical Director of the University Hospitals Seidman Cancer Center Clinical Trials Unit.
In addition, he is an Associate Professor of the Case Western Reserve University School of Medicine.
Dr. Gibson is board certified in Medical Oncology. His special interests are upper gastro-intestinal tract (esophagus and stomach) and head and neck cancers. He joined the staff of University Hospitals in 2013, after serving as Director of Esophageal Cancer Research in the Departments of Cardiothoracic Surgery and Medical Oncology at the University of Pittsburgh Medical Center.
Dr. Gibson’s research interest is in bringing novel therapeutics to the treatment of aero-digestive cancers, based on rational pre-clinical investigation and in the setting of a patient focus. He has published nearly four dozen papers in peer-reviewed journals on such topics as treatment of esophageal cancer with chemo-radiotherapy, and novel drug therapies for head and neck cancer. He is a reviewer for many medical publications, including the American Journal of Clinical Oncology, the International Journal of Radiation Oncology, Biology, Biophysics; and the Journal of Clinical Oncology. He is a frequent presenter at local, regional, national and international medical meetings and conferences.
He is a Chair of the Upper Gastrointestinal Subcommittee of the Eastern Cooperative Oncology Group, Member of the National Cancer Institute Esophago-gastric Task Force and is a Fellow in the American College of Physicians.
Dr. Gibson graduated with bachelor’s degrees in biochemistry and microbiology from North Carolina State University in Raleigh, N.C. After obtaining his MD from Johns Hopkins, he completed an Osler Medical Residency and Medical Oncology Fellowship at Johns Hopkins Hospital while concurrently earning a PhD in Clinical Investigation from the Johns Hopkins University Bloomberg School of Public Health.
American Board of Internal Medicine - Medical Oncology
Education & Training
1991, North Carolina State University
Medical / Professional School(s)
1996, Johns Hopkins University School of Medicine
1999, Internal Medicine - Johns Hopkins Hospital
2004, Medical Oncology - Johns Hopkins Hospital
Esophageal Cancer, Aerodigestive Cancer, Head and Neck Cancer
Awards & Recognition
- Leo Criep, MD Excellence in Patient Care Award, UPCI and UPMC Cancer Centers, 2011
- Fellow Research Day Poster Session First Place, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 2004
- ASCO Young Investigator Award 2003
UH Seidman Cancer Center
11100 Euclid Ave
Department of Medicine-Hematology and Oncology
Esophago-gastric Cancer, Head and Neck Cancer, Clinical Investigation, Translational Therapeutics
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Michael Gibson, MD, PhD did not disclose any Outside Relationships with Industry.